HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

NCT02513147 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

HIV-1

Interventions

DRUG: Dolutegravir
DRUG: PI
DRUG: 2 NRTI
DRUG: 2 NRTI

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Collaborators

[object Object]
[object Object]